Brian Shaffer, MD

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome (MDS)

Dr. Shaffer's research focuses on the role of Natural Killer (NK) cells in outcomes after transplantation. NK cells are white blood cells that have anti-tumor and anti-infection properties. His goal is to improve the transplantation process for patients via understanding and optimizing NK cell behavior. His clinical interests also include improving transplantation methods for patients without a matched sibling donor.